Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
angelica gigas nakai ethanol extract
- Development stage
- Preclinical
- Lead developer
- Myongji University
- Administration
- Oral
01
Overview
Angelica gigas Nakai ethanol extract is a high-purity plant extract derived from the roots of Angelica gigas Nakai using ethanol as the extraction solvent[1][2]. The primary active constituents are decursin and decursinol angelate, which can comprise over 90% of the purified extract[2]. This substance is studied for its antithrombotic, anti-platelet aggregation, and antioxidant effects, showing significant potential in reducing thrombus formation and preventing ischemic stroke while exhibiting lower bleeding risk compared to acetylsalicylic acid[1]. The extract also demonstrates free radical scavenging properties and potential for blood circulation improvement, anti-inflammatory, neuroprotective, kidney toxicity inhibition, and metabolic disorder protection[1][2]. It is used in research as a natural alternative for cardiovascular and circulatory disorders and is considered for pharmaceutical and nutraceutical development.
- Brand names
- AGE 232AGE232AGE-232
- Other names
- Angelica gigas Nakai ethanol extractAngelica gigas extract참당귀 에탄올 추출물
02
Targets
PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on angelica gigas nakai ethanol extract.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on angelica gigas nakai ethanol extract.